For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
At no time has it been more vital to ensure research data is collected rapidly and accurate answers found. Fast, reproducible results are essential for supporting all aspects of coronavirus research. This webinar will showcase how SimpleStep ELISA® assays have evolved to deliver quick results and give the highest level of confidence in your data.
Join Abcam’s senior scientists Teri Girtsman Ph.D. and Anne Dickson Ph.D., as they discuss the science around COVID-19 and how Abcam’s SimpleStep ELISA range offers key validated assays that can be used to increase our understanding of this disease and move us towards a faster solution.
On-demand webinar presenters
Anne Dickson Ph.D., Senior Scientist, New Product Development
As a native of St. Paul, Minnesota, Anne received a doctorate in biochemistry from the University of Iowa. She has worked in academic research, biotechnology R&D, and teaching environments, with a broad experience from gene therapy for infectious disease to flow cytometry reagent development. While scientifically adaptable and curious, she has a keen interest in antibodies and modulation of the immune system.
Teri Girtsman Ph.D., Senior Scientist, Immunoassays
Teri gained both a Bachelor and Master of Science in molecular cell biology and a Ph.D. in toxicology, specializing in immunotoxicology. In addition to her NRSA Postdoctoral Fellowship in respiratory immunotoxicology, her past research has focused upon nanomaterial-induced lung inflammation.
Q&A panelist presenters
James Murray Ph.D., Director of Immunoassay Development and Eugene Site Head
James was the lead scientist at MitoSciences Inc acquired by Abcam in 2011. MitoSciences was an RUO provider of monoclonal antibodies and assay kits addressing the research areas of mitochondria and metabolism. Since joining Abcam James and his team have been involved in establishing a rabbit monoclonal antibody pair development platform in Abcam, Hangzhou, and establishing the immunoassay kit development platforms - SimpleStep ELISA and Fireplex Multiplex ELISA at Abcam, Eugene, using these novel antibody pairs. All antibody pairs are available to our customer and assay platform partners as kit reagents and separate reagents for your own assay needs.
Scott Detmer Ph.D., Head of SimpleStep ELISA Development
Scott Detmer leads the team that validates and develops SimpleStep ELISA products. Prior to working at Abcam, Scott designed cellular pharmacology assays at Exelixis, Inc. and earned his Ph.D. at Caltech studying mitochondrial dynamics.
Jeff Monette Ph.D., Senior Scientist, Immunoassay Design
As a research and development scientist, Jeff is responsible for the design and validation of new targets in support of our SimpleStep ELISA product line, as well as feasibility assessment for novel technologies related to immunoassay development.
Have questions about this webinar? Contact us at email@example.com